Clinical impact of additional therapy for residual pancreatic cancer

ConclusionsNAT was a significant predictor of R0 resection. When patients completed AC, there were no marked differences in the OS or DFS between R0 and R1 resection. Our results demonstrated that the clinical impact of the R1 status has waned in the current era of PDAC management.
Source: Surgery Today - Category: Surgery Source Type: research